Effects of UDCA and probiotics on metabolic outcomes in type 2 diabetes patients on metformin: A randomized trial in Bosnia and Herzegovina
was highest in the MPUG group. No serious adverse events were reported.ConclusionCo-administration of probiotics and UDCA for four weeks in metformin-treated T2D patients significantly improves short-term glycemic control and lipid profiles. These promising results warrant validation in larger, longer-term clinical trials.
Authors
- Alma Badnjević-Čengić
- Sara Deumić (ORCID: https://orcid.org/0009-0009-3022-2097)
- Tamer Bego (ORCID: https://orcid.org/0000-0002-1350-7084)
- Hani Al‐Salami (ORCID: https://orcid.org/0000-0003-0049-6969)
- Damira Kadić (ORCID: https://orcid.org/0000-0001-5860-9896)
- Neven Meseldžić (ORCID: https://orcid.org/0000-0002-1949-0789)
- Momir Mikov (ORCID: https://orcid.org/0000-0002-2804-0624)
- Ranko Škrbić (ORCID: https://orcid.org/0000-0002-6643-1781)
- Neira Crnčević (ORCID: https://orcid.org/0009-0005-2686-5461)
- Nataša Stojaković (ORCID: https://orcid.org/0000-0002-1140-804X)
- Adna Softić (ORCID: https://orcid.org/0000-0003-4996-7469)
- Armin Mooraniana
Institutions
- University of Siena (IT)
- University of Sarajevo (BA)
- University of Novi Sad (RS)
- University of Banja Luka (BA)
- The University of Western Australia (AU)
- Sechenov University (RU)
- University of Zenica (BA)
- Curtin University (AU)
- Verlab (Bosnia and Herzegovina) (BA)
- International Burch University (BA)
- University of Otago (NZ)
Publication Details
- Journal
- Technology and Health Care
- Published
- 2026-04-25
- DOI
- https://doi.org/10.1177/09287329261438698
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00